Skip to content

Public FDA record

Z-1236-2026: VITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n) o Ceftazidime/avibactam (cza0

Recall record Z-1236-2026 for Biomerieux Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1236-2026
Company in FDA record
Biomerieux Inc
FDA classification date
Feb 2, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Potential risk of Quality Control failures and/or false resistant antibiotic results when testing isolates of Enterobacterales/Enterobacteriaceae species and/or Pseudomonas aeruginosa with the identified antibiotic formulations. Issue may lead to QC failure or false resistant results.

Source facts

Action
Customers with clinically significant isolates of Enterobacterales species and Pseudomonas aeruginosa with resistant results to Ceftazidime/Avibactam (cza02n), Imipenem (ipm05n), Imipenem/Relebactam (ipr01n), Meropenem/Vaborbactam (mev01n), or Polymyxin B (pb02n) should consider using an alternative method to confirm results. The determination of clinical significance should be made by each laboratory based on the antimicrobial susceptibility profile and the local availability of alternative antibiotics. Customers can set up a custom bioART rule to trigger when resistant results are obtained for the impacted bug drug combinations above. Based on individual customer policy, customers may wish to perform retrospective review of resistant results. ***Update*** On 4/2/26, the firm added additional products to the scope of the recall. The additional product was not manufactured at the time of the original notification, and the additional products are distributed OUS only.
Initiated
2026-01-05
Root cause
Under Investigation by firm
Distribution
Worldwide - US Nationwide distribution.
Recall number
Z-1236-2026
Recall status
Open, Classified
CDRH record ID
218083
FDA classified
2026-02-02
Recall event number
98268

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗